Galgravin is primarily used in pharmaceutical research due to its bioactive properties. It exhibits significant antioxidant and anti-inflammatory effects, making it a candidate for development in treatments targeting oxidative stress-related diseases such as neurodegenerative disorders and cardiovascular conditions. Studies also suggest potential antimicrobial activity, which could be leveraged in new antimicrobial agents. Additionally, galgravin has shown cytotoxic effects against certain cancer cell lines, indicating its promise in oncology research for developing novel anticancer drugs. Its natural origin and low toxicity profile further support its use in medicinal chemistry and drug discovery.